420 PROSTVAC in combination with nivolumab enhanced immune cell infiltration in prostate cancer

Similar Items

• 587 Nivolumab increased vaccine induced T-cell infiltration in Prostate cancer
  by: James L Gulley, et al.
  Published: (2023-11-01)
• 913 Tumor immune micro-environment (TIME) Atlas for prostate cancer bone metastasis
  by: James L Gulley, et al.
  Published: (2023-11-01)
• Development and validation of a Luminex assay for detection of a predictive biomarker for PROSTVAC-VF therapy.
  by: Julie L Lucas, et al.
  Published: (2017-01-01)
• Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer
  by: Arun Rajan, et al.
  Published: (2024-03-01)
• Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer
  by: Jason M. Redman, et al.
  Published: (2023-06-01)